We're not waiting for Congress to act. NIH is already investing nearly $50 million in Lyme disease research and another 122 million in tick borne disease research, including prevention, diagnostics and treatment. Our goal is clear. Reduce Lyme disease case by 25% by 2035 compared to 2022 levels. Today, my agency is launching a major new multimillion dollar pilot program that has the potential to transform how we prevent Lyme disease and other tick borne illnesses in America. (06:38–06:47)
CLAIM
Asserts a goal to reduce Lyme disease cases by 25% by 2035 compared to 2022.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
